Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,773 public trials 498 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

NCT00019448

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: Surgery Branch Bethesda, Maryland, United States

View Trial Details

Completed

Characteristics and Tumor Staging Proposal for Primary Malignant Melanoma of the Esophagus

NCT06291753

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +17 more
Locations: Qianwen Liu Guangzhou, Guangdong, China

View Trial Details

Completed

Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma

NCT00019890

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations: Not specified

View Trial Details

Completed

The Impact of a Prevention Program on Sun Risks in Primary School in Tropical French Region

NCT05367180

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: CHU de La Réunion Saint-Pierre, Reunion

View Trial Details

Completed

Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists

NCT02126579

Conditions: Melanoma, Metastatic Melanoma, Mucosal Melanoma, +11 more
Locations: MDAnderson Cancer Center Houston, Texas, United States

University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types

NCT03012620

Conditions: Adenocarcinoma, Adnexal Diseases, Carcinoma, +37 more
Locations: Gustave Roussy Cancer Campus Villejuif, France

View Trial Details

Completed

Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery

NCT03008369

Conditions: Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma, +9 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Understanding Immunotherapy Resistance Mechanisms in Advanced Melanoma

NCT02694965

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors

NCT01525082

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +25 more
Locations: Stanford University Medical Center Stanford, California, United States

View Trial Details

Completed

Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer

NCT00390325

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +31 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

Duke University Medical Center Durham, North Carolina, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions